Market Place
Sourcing Support
Nucleai Highlights AI Biomarkers for Lung & Skin Cancer at SITC
05 Nov 2024 //
BUSINESSWIRE
Nucleai Appoints Vikas Ahuja As VP Strategic Partnerships
16 May 2024 //
BUSINESSWIRE
Nucleai and GoPath Announce Strategic Collaboration
08 Apr 2024 //
BUSINESSWIRE
Nucleai Unveils Breakthrough AI Spatial Biomarker Advancements at AACR 2024
05 Apr 2024 //
BUSINESSWIRE
M Ventures Arm Backs Nucleai to Advance AI Bio in Active Clinical Enrollment
03 Apr 2024 //
BUSINESSWIRE
Nucleai & Adlai Partner to Identify Spatial Biomarkers Across Adlai Trials
31 May 2023 //
BUSINESSWIRE
Nucleai Expands Leadership Team & Scientific Advisory Board with Pharma Experts
24 May 2023 //
BUSINESSWIRE
Nucleai Expands Scientific Advisory Board with Oncology Industry Luminary
08 Nov 2022 //
BUSINESSWIRE
Nucleai Launches New Multiplex Imaging Spatial Analysis Solution
07 Nov 2022 //
BUSINESSWIRE
Nucleai & Propath announce partnership for AI-powered spatial analysis
21 Sep 2022 //
BUSINESSWIRE
Lunaphore and Nucleai announce a partnership
08 Sep 2022 //
BUSINESSWIRE
Nucleai Announces Better Prediction of Response to Immune Checkpoint Inhibitors
06 Sep 2022 //
BUSINESSWIRE
Nucleai, Sirona Dx Partner for AI-Driven Discovery of Novel Spatial Biomarkers
13 Jul 2022 //
BUSINESSWIRE
Nucleai to Publish Pathology-based Data at ASCO 2022 for PII Research in NHL
04 Jun 2022 //
BUSINESSWIRE
Nucleai Partners with Ultivue for AI-Powered Spatial Biology Analysis
02 Jun 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.